Literature DB >> 24149849

Systematic review and meta-analysis of endoscopic submucosal dissection versus transanal endoscopic microsurgery for large noninvasive rectal lesions.

Alberto Arezzo1, Roberto Passera, Yutaka Saito, Taku Sakamoto, Nozomu Kobayashi, Naoto Sakamoto, Naohisa Yoshida, Yuji Naito, Mitsuhiro Fujishiro, Keiko Niimi, Tomohiko Ohya, Ken Ohata, Shinichi Okamura, Shinei Iizuka, Yoji Takeuchi, Noriya Uedo, Pietro Fusaroli, Marco Augusto Bonino, Mauro Verra, Mario Morino.   

Abstract

BACKGROUND: For almost 30 years, transanal endoscopic microsurgery (TEM) has been the mainstay treatment for large rectal lesions. With the advent of endoscopic submucosal dissection (ESD), flexible endoscopy has aimed at en bloc R0 resection of superficial lesions of the digestive tract. This systematic review and meta-analysis compared the safety and effectiveness of ESD and full-thickness rectal wall excision by TEM in the treatment of large nonpedunculated rectal lesions preoperatively assessed as noninvasive.
METHODS: A systematic review of the literature published between 1984 and 2010 was conducted (Registration no. CRD42012001882). Data were integrated with those from the original databases requested from the study authors when needed. Pooled estimates of the proportions of patients with en bloc R0 resection, complications, recurrence, and need for further treatment in the ESD and TEM series were compared using random-effects single-arm meta-analysis.
RESULTS: This review included 11 ESD and 10 TEM series (2,077 patients). The en bloc resection rate was 87.8 % (95 % confidence interval [CI] 84.3-90.6) for the ESD patients versus 98.7 % (95 % CI 97.4-99.3 %) for the TEM patients (P < 0.001). The R0 resection rate was 74.6 % (95 % CI 70.4-78.4 %) for the ESD patients versus 88.5 % (95 % CI 85.9-90.6 %) for the TEM patients (P < 0.001). The postoperative complications rate was 8.0 % (95 %, CI 5.4-11.8 %) for the ESD patients versus 8.4 % (95 % CI 5.2-13.4 %) for the TEM patients (P = 0.874). The recurrence rate was 2.6 % (95 % CI 1.3-5.2 %) for the ESD patients versus 5.2 % (95 % CI 4.0-6.9 %) for the TEM patients (P < 0.001). Nevertheless, the rate for the overall need of further abdominal treatment, defined as any type of surgery performed through an abdominal access, including both complications and pathology indications, was 8.4 % (95 % CI 4.9-13.9 %) for the ESD patients versus 1.8 % (95 % CI 0.8-3.7 %) for the TEM patients (P < 0.001).
CONCLUSIONS: The ESD procedure appears to be a safe technique, but TEM achieves a higher R0 resection rate when performed in full-thickness fashion, significantly reducing the need for further abdominal treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24149849     DOI: 10.1007/s00464-013-3238-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  35 in total

Review 1.  Pit pattern in colorectal neoplasia: endoscopic magnifying view.

Authors:  S Kudo; C A Rubio; C R Teixeira; H Kashida; E Kogure
Journal:  Endoscopy       Date:  2001-04       Impact factor: 10.093

2.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Hiroya Takiuchi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2011-10-15       Impact factor: 3.402

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

4.  Transanal endoscopic microsurgery is superior to transanal excision of rectal adenomas.

Authors:  E J R de Graaf; J W A Burger; A L A van Ijsseldijk; G W M Tetteroo; I Dawson; W C J Hop
Journal:  Colorectal Dis       Date:  2010-03-23       Impact factor: 3.788

5.  Risk factors for recurrence after transanal endoscopic microsurgery for rectal malignant neoplasm.

Authors:  Mario Morino; Marco Ettore Allaix; Mario Caldart; Gitana Scozzari; Alberto Arezzo
Journal:  Surg Endosc       Date:  2011-06-07       Impact factor: 4.584

6.  Long-term outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms.

Authors:  K Niimi; M Fujishiro; S Kodashima; O Goto; S Ono; K Hirano; C Minatsuki; N Yamamichi; K Koike
Journal:  Endoscopy       Date:  2010-08-30       Impact factor: 10.093

7.  Transanal endoscopic excision of rectal adenomas.

Authors:  C Cocilovo; L E Smith; T Stahl; J Douglas
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

8.  Endoscopic submucosal dissection for colorectal tumors.

Authors:  H Iizuka; S Okamura; Y Onozato; H Ishihara; S Kakizaki; M Mori
Journal:  Gastroenterol Clin Biol       Date:  2009-09-16

9.  Technique of transanal endoscopic microsurgery.

Authors:  G Buess; K Kipfmüller; D Hack; R Grüssner; A Heintz; T Junginger
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

10.  Impact of transanal endoscopic microsurgery on functional outcome and quality of life.

Authors:  P G Doornebosch; M P Gosselink; P A Neijenhuis; W R Schouten; R A E M Tollenaar; E J R de Graaf
Journal:  Int J Colorectal Dis       Date:  2008-04-01       Impact factor: 2.571

View more
  41 in total

Review 1.  Transanal Endoscopic Microsurgery.

Authors:  Theodore John Saclarides
Journal:  Clin Colon Rectal Surg       Date:  2015-09

2.  Efficacy and safety of laparo-endoscopic resections of colorectal neoplasia: A systematic review.

Authors:  Alberto Arezzo; Roberto Passera; Marco Migliore; Roberto Cirocchi; Giuseppe Galloro; Raffaele Manta; Mario Morino
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

Review 3.  Local Excision and Endoscopic Resections for Early Rectal Cancer.

Authors:  Guilherme Pagin São Julião; Juan Pablo Celentano; Flavia Andrea Alexandre; Bruna Borba Vailati
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 4.  [Management of complications in anal and transanal tumor surgery].

Authors:  M Sailer; S Eisoldt; C Möllmann
Journal:  Chirurg       Date:  2015-08       Impact factor: 0.955

Review 5.  Endoscopic submucosal dissection versus local excision for early rectal cancer: a systematic review and meta-analysis.

Authors:  S Wang; S Gao; W Yang; S Guo; Y Li
Journal:  Tech Coloproctol       Date:  2015-10-30       Impact factor: 3.781

Review 6.  ESD and Pit Pattern Diagnosis: Lessons from a Japanese Endoscopist Working in the United States.

Authors:  Makoto Nishimura
Journal:  Clin Colon Rectal Surg       Date:  2020-09-04

Review 7.  Management of Rectal Polyps.

Authors:  Michelle L Cowan; Matthew L Silviera
Journal:  Clin Colon Rectal Surg       Date:  2016-12

8.  Endoscopic submucosal dissection (ESD) versus transanal endoscopic microsurgery (TEM) for treatment of rectal tumors: a comparative systematic review and meta-analysis.

Authors:  Thomas R McCarty; Ahmad Najdat Bazarbashi; Kelly E Hathorn; Christopher C Thompson; Hiroyuki Aihara
Journal:  Surg Endosc       Date:  2019-07-10       Impact factor: 4.584

Review 9.  Endoluminal Therapy in Colorectal Cancer.

Authors:  Katherine A Kelley; V Liana Tsikitis
Journal:  Clin Colon Rectal Surg       Date:  2016-09

10.  Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors.

Authors:  Takeshi Mizushima; Mototsugu Kato; Ichiro Iwanaga; Fumiyuki Sato; Kimitoshi Kubo; Nobuyuki Ehira; Minoru Uebayashi; Shouko Ono; Manabu Nakagawa; Katsuhiro Mabe; Yuichi Shimizu; Naoya Sakamoto
Journal:  Surg Endosc       Date:  2014-07-04       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.